Abstract
Post-transplant lymphoproliferative syndrome (PFS) confined to the central nervous system (CNS) is an extremely rare and poor prognosis. The treatment has a significant impact on survival. This standard is not clearly given the low incidence of this condition and therefore there is little literature. Radiotherapy is an alternative treatment in these patients with involvement in the CNS. A review of the main characteristics of this pathology was conducted and a case of a patient of 13 years old with CNC SLPT confined to the only site of involvement, treated with radiotherapy getting a good response, adequate tolerance to treatment.
Dharnidharka VR, Green M, Weber SA, editores. Posttransplant lymphoproliferative disorders. Berlin: Springer Verlag; 2010.
Jamali FR, Otrock ZK, Soweid AM, Al-awar GN, Mahfouz RA, Haidar GR, Bazarbachi A. An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma. Leuk Lymphoma. 2007 Jun;48(6):1237-41.
Swerdlow SH. T cell and NK-cell post-transplantation lymphoproliferative disorders. Am J Clin Pathol. 2007;127(6):887-95.
Dharnidharka VR. Epidemiology of PTLD. In: Dharnidharka VR, editor. Posttransplant lymphoproliferative disorders. Berlin: Springer Verlag; 2010. p. 17-28.
Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56(1):155-67.
Cavaliere R, Petroni G, Lopes M et al. Primary central nervous system posttransplantation lymphoproliferative disorder: An International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer. 2010 Jul;15;116(14):3521.
Phan TG, O’Neill BP, Kurtin PJ. Posttransplant primary CNS lymphoma. Neuro Oncology. 2000;2:229-38.
Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation 1995;59(2):240-4.
Morgans A, Reshef R, Tsai DE. Posttransplant lymphoproliferative disorder following kidney transplant. Am J Kidney Dis. 2010 Jan;55(1): 168-80.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.